Disposition of netobimin, albendazole, and its metabolites in the pregnant rat: Developmental toxicity

Toxicology and Applied Pharmacology

Volumn 144, Issue 1, 1997, Pages 56-61

  Cristòfol, Carles ^a   Navarro, Marc ^a   Franquelo, Carme ^a   Valladares, Josep Enric ^a   Carretero, Ana ^a   Ruberte, Jesus ^a   Arboix, Margarita ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ALBENDAZOLE SULFONE; ALBENDAZOLE SULFOXIDE; ANTHELMINTIC AGENT; DRUG METABOLITE; NETOBIMIN; PRODRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; DRUG BLOOD LEVEL; DRUG DISPOSITION; DRUG METABOLISM; FEMALE; FETOTOXICITY; FETUS; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT;

ANIMALIA;

EID: 17344389497     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1997.8114     Document Type: Article

References (26)

1. Baker H. J., Russell J., Weifbroth S. H. Embryology and teratology. The Laboratory Rat. Biology and Diseases. American College of Laboratory Animal Medicine Series. 1979;. p. 78-81.
2. Bogan J. A., Marriner S. E. Analysis of benzimidazoles in body fluids by high performance liquid chromatography. J. Pharm. Sci. 69:1980;422-423.
3. Cristòfol C., Carretero A., Fernandez M., Navarro M., Sautet J., Ruberte J., Arboix M. Transplacental transport of netobimin metabolites in ewes. Eur. J. Drug Metab. Pharmacokin. 20:1995;167-171.
4. Delatour P., Cure M. C., Benoit E., Garnier F. Netobimin (Totabin-SCH): Preliminary investigations on metabolism and pharmacology. J. Vet. Pharmacol. Ther. 9:1986;230-234.
5. Delatour P., Garnier F., Benoit E., Longin CH. A correlation of toxicity of albendazole and oxfendazole with their free metabolites and bound residues. J. Vet. Pharmacol. Ther. 7:1984;139-145.
6. Delatour P., Parish R. Benzimidazole anthelmintics and related compounds: Toxicity and evaluation of residues. Drug Residues in Animals. 1986;Academic Press, New York. p. 175-203.
7. Delatour P., Parish R. C., Gyurik R. J. Albendazole: A comparison of relay embryotoxicity with embryotoxicity of individual metabolites. Ann. Rech. Vét. 12:1981;159-167.
8. Delatour P., Yoshimura H., Garnier F., Benoit E. Embryotoxicité comparée des metabolites de l'oxfendazole. Rec. Méd. Vét. 158:1982;369-373.
9. Fabre J. M., Berthelot X., Ferney J. Embryotoxicité des antiparasitaires chez les ovins: Observation clinique. Rev. Méd. Vét. 140:1989;1089-1095.
10. Gyurik R. J., Chow A. W., Zaber B., Brunner E. L., Miller J. A., Villani A. J., Petka L. A., Parish R. C. Metabolism of albendazole in cattle, sheep, rats and mice. Drug Metab. Dispos. 9:1981;503-508.
11. Lacey E., Watson T. R. Structure-activity relationships of benzimidazole carbamates as inhibitors of mammalian tubulin,in vitro. Biochem. Pharmacol. 34:1985;1073-1077.
12. Lanusse C. E., Prichard R. K. Pharmacokinetic behaviour of netobimin and its metabolites in sheep. J. Vet. Pharmacol. Ther. 13:1990;179-185.
13. D. Martin, 1980, Albendazole: Étude embryotoxique de dix métabolites, Ecole Nationale Vétérinaire de Lyon, France.
14. Mantovani A., Macri C., Stazi A. V., Riccciardi C. Effects of albendazole on early phases of rat organogenesis "in vivo": Preliminary results. Eur. Teratol. Abst. 46:1992;P22.
15. McCracken R. O., Stillwell W. H. A possible mode of action for benzimidazole anthelmintics. Int. J. Parasitol. 7:1991;99-104.
16. M. Navarro, 1996, Efectos embriotóxicos del netobimin en la oveja, la rata y el pollo, Publicacions UAB, Barcelona.
17. Richards L. S., Zimmerman G. L., Hoberg E. P., Schons D. J., Dawley S. W. The anthelmintic efficacy of netobimin against acquired gastrointestinal nematodes in sheep. Vet. Parasitol. 26:1987;87-94.
18. Santiago M. A., Da Costa U. C., Benevenga S. F. Netobimin (Totabin-SCH) efficacy in ruminants in Rio Grande Do Sud Brazil. World Assoc. Adv. Vet. Parasitol. Abst. 130:1985;30.
19. Schümaker R. C. Pkcalc: A basic interactive computer program for statistical and pharmacokinetic analysis of data. Drug Metab. Rev. 17:1986;331-348.
20. Souhaili-el Amri H., Fargetton X., Delatour P., Bat A. M. Sulphoxidation of albendazole by the FAD-containing and cytochrome P-450 dependent monooxigenases from pig liver microsomes. Xenobiotica. 17:1987;1159-1168.
21. Souhaili-el Amri H., Mothe O., Totis M., Batt A. M., Delatour P., Siest G. Albendazole sulfonation by rat liver cytochrome P-450c. J. Pharmacol. Exp. Ther. 246:1988;758-764.
22. Staples R. E., Schnell V. L. Refinements in rapid clearing technic in the KOH-Alizarin red S method for fetal bone. Stain Technol. 39:1964;61.
23. Whittaker S. G., Faustman E. M. Effects of albendazole sulfoxide on cultures of differentiating rodent embryonic cells. Toxicol. Appl. Pharmacol. 109:1991;73-84.
24. Whittaker S. G., Faustman E. M. Effects of benzimidazole analogs on cultures of differentiating rodent embryonic cells. Toxicol. Appl. Pharmacol. 113:1992;144-151.
25. Williams J. C., Knox J. W., Marbury K. S., Kimball M. D., Willis E. R., Sneider T. G., Miller J. E. Efficacy of SCH 32481 against inhibited larvae ofOstertagia ostertagi. Am. J. Vet. Res. 46:1985;2188-2192.
26. Yoshimura H. Teratogenic evaluation of triclabedazole in rats. Toxicology. 43:1987;283-287.